过度表达通过通过TLR4/MyD88/NF-κB信号通路促进自,抑制分散型大B细胞淋巴瘤的进展
Fangying Ning1,2, Huafang Wang2, Zuyu Liang2
1Suzhou Medical College of Soochow University, 215006 Suzhou, Jiangsu, China.
Discovery medicine
|August 27, 2024
概括
瘤缩因子α诱导蛋白3 (TNFAIP3) 通过诱导自抑制扩散性大B细胞淋巴瘤 (DLBCL) 的进展. 这种TNFAIP3介导的自抑制瘤生长,并增强DLBCL细胞的亡.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤亡因子α诱导蛋白3 (TNFAIP3) 在各种癌症中起着自调节的作用.
- 它在扩散性大B细胞淋巴瘤 (DLBCL) 中的特定功能需要进一步阐明.
研究的目的:
- 研究TNFAIP3在DLBCL中的作用和机制.
- 为了确定TNFAIP3是否调节DLBCL进展中的自.
主要方法:
- 利用基因表达总量 (GEO) 数据库用于DLBCL中TNFAIP3的差异表达和预后分析.
- 采用了qRT-PCR,西部斑点,CCK-8,殖民地形成,Transwell和流动细胞计测试来评估TNFAIP3表达,增殖,迁移和亡.
- 通过免疫光学,传输电子显微镜和关键标记者的西方抹杀来研究自 (LC3II/LC3I,p62).
- 分析了TLR4/MyD88/NF-κB信号通路和Ki67的表达.
主要成果:
- 在DLBCL样本和细胞中发现TNFAIP3表达的下调,与预后不佳相关.
- TNFAIP3抑制了增殖和迁移,同时增强了DLBCL细胞的亡 (OCI-LY3).
- 通过TLR4/MyD88/NF-κB通路,TNFAIP3诱导了自,其上调抑制了体内瘤的生长.
结论:
- 在DLBCL中,TNFAIP3充当瘤抑制剂.
- 通过TLR4/MyD88/NF-κB信号通路诱导自,TNFAIP3对DLBCL进展的抑制作用受到介导.
关键词:
TLR4 / MyD88 / NF-κBB / TLR4 / MyD88 / NF-κBB / TLR4 / MyD88 / MyD88 / NF-κBB / TLR4 / MyD88 / MyD88 / MyD88 / TLR4 / MyD88 / MyD88 / TLR4 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88 / MyD88自自是自的过程.扩散大的B细胞淋巴瘤.相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


